All Stories

  1. Copper(II) complexes with non-steroidal anti-inflammatory drugs and neocuproine: Structure and biological evaluation
  2. Cu(ii) complexes with a salicylaldehyde derivative and α-diimines as co-ligands: synthesis, characterization, biological activity. Experimental and theoretical approach
  3. Neutral and cationic nickel(II) complexes with substituted salicylaldehydes: Characterization, antibacterial activity, and interaction with biomacromolecules
  4. Transition metal(II) complexes with the non–steroidal anti–inflammatory drug oxaprozin: Characterization and biological profile
  5. Erbium(III) coordination compounds with substituted salicylaldehydes: Characterization and biological profile
  6. pH-Sensitive Gold Nanorods for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery and DNA-Binding Studies
  7. Iron(III) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure, Antioxidant and Anticholinergic Activity, and Interaction with Biomolecules
  8. Metal Complexes with Naphthalene-Based Acetic Acids as Ligands: Structure and Biological Activity
  9. Effect of Arylazo Sulfones on DNA: Binding, Cleavage, Photocleavage, Molecular Docking Studies and Interaction with A375 Melanoma and Non-Cancer Cells
  10. Copper(II) complexes with 3,5–dihalogeno–salicylaldehydes: Synthesis, structure and interaction with DNA and albumins
  11. Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH3-Substituted Thiadiazole-Based Thioamide
  12. Copper(II) Complexes of 5–Fluoro–Salicylaldehyde: Synthesis, Characterization, Antioxidant Properties, Interaction with DNA and Serum Albumins
  13. Copper(II) complexes with 4-(diethylamino)salicylaldehyde and α-diimines: Anticancer, antioxidant, antigenotoxic effects and interaction with DNA and albumins
  14. Palladium(II) Complexes of Substituted Salicylaldehydes: Synthesis, Characterization and Investigation of Their Biological Profile
  15. In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins
  16. Metal(II) Complexes of the Fluoroquinolone Fleroxacin: Synthesis, Characterization and Biological Profile
  17. Structure and in vitro and in silico biological activity of zinc(II) complexes with 3,5–dichloro–salicylaldehyde
  18. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity
  19. Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study
  20. Manganese(II) complexes of substituted salicylaldehydes and α-diimines: Synthesis, characterization and biological activity
  21. Zinc(II) complexes of 3,5–dibromo–salicylaldehyde and α–diimines: Synthesis, characterization and in vitro and in silico biological profile
  22. Stimuli-responsive spin crossover nanoparticles for drug delivery and DNA-binding studies
  23. Zinc(ii) complexes of 3-bromo-5-chloro-salicylaldehyde: characterization and biological activity
  24. Transition metal(ii) complexes of halogenated derivatives of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: structure, antioxidant activity, DNA-binding DNA photocleavage, interaction with albumin andin silicostudies
  25. Copper(II) complexes with non–steroidal anti–inflammatory drugs: Structural characterization, in vitro and in silico biological profile
  26. Synthesis, characterization and (in vitro and in silico) biological activity of a series of dioxouranium(VI) complexes with non-steroidal anti-inflammatory drugs
  27. Nickel(II)–meclofenamate complexes: Structure, in vitro and in silico DNA– and albumin–binding studies, antioxidant and anticholinergic activity
  28. Structure and biological profile of transition metal complexes with (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline
  29. Trinuclear and tetranuclear iron(III) complexes with fenamates: Structure and biological profile
  30. Copper(II) complexes with meclofenamate ligands: Structure, interaction with DNA and albumins, antioxidant and anticholinergic activity
  31. Interaction of manganese(II) with the hybrid molecule (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: Structure and biological profile
  32. Synthesis, structural determination, in vitro and in silico biological evaluation of divalent or trivalent cobalt complexes with indomethacin
  33. Facile Method to Prepare pH-Sensitive PEI-Functionalized Carbon Nanotubes as Rationally Designed Vehicles for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery
  34. Zn(II) complexes of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline in combination with non-steroidal anti-inflammatory drug sodium diclofenac: Structure, DNA binding and photo-cleavage studies, antioxidant activity and interaction with albumin
  35. Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA
  36. Structure and biological evaluation of pyridine-2-carboxamidine copper(II) complex resulting from N′-(4-nitrophenylsulfonyloxy)2-pyridine-carboxamidoxime
  37. Copper(II) and zinc(II) coordination compounds of non-steroidal anti-inflammatory drugs: Structural features and antioxidant activity
  38. Transition metal complexes with a novel guanine-based (E)-2-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazolin-4(3H)-one: Synthesis, characterization, interaction with DNA and albumins and antioxidant activity
  39. p-Pyridinyl oxime carbamates: synthesis, DNA binding, DNA photocleaving activity and theoretical photodegradation studies
  40. Manganese(II) coordination compounds of carboxylate non-steroidal anti-inflammatory drugs
  41. Novel copper(ii) complexes with fenamates and isonicotinamide: structure and properties, and interactions with DNA and serum albumin
  42. A palladium(II) complex with the Schiff base 4-chloro-2-(N-ethyliminomethyl)-phenol: Synthesis, structural characterization, and in vitro and in silico biological activity studies
  43. Bi- and trinuclear copper(I) compounds of 2,2,5,5-tetramethyl-imidazolidine-4-thione and 1,2-bis(diphenylphosphano)ethane: Synthesis, crystal structures, in vitro and in silico study of antibacterial activity and interaction with DNA and albumins
  44. Cobalt(II) complexes with the non-steroidal anti-inflammatory drug diclofenac and nitrogen-donor ligands
  45. Synthesis, characterization and biological activity of Zn coordination compounds with the quinolone gatifloxacin
  46. Zinc-oxaprozin compounds: Synthesis, structure and biological activity
  47. Homoleptic and heteroleptic silver(I) complexes bearing diphosphane and thioamide ligands: Synthesis, structures, DNA interactions and antibacterial activity studies
  48. Organometallic rhenium tricarbonyl–enrofloxacin and –levofloxacin complexes: synthesis, albumin-binding, DNA-interaction and cell viability studies
  49. Palladium(II) complexes with salicylaldehyde ligands: Synthesis, characterization, structure, in vitro and in silico study of the interaction with calf-thymus DNA and albumins
  50. Manganese coordination compounds of mefenamic acid: In vitro screening and in silico prediction of biological activity
  51. Manganese(II) complexes of tolfenamic acid or naproxen in polymeric structures or encapsulated in [15-MC-5] manganese(III) metallacrowns: Structure and biological activity
  52. Copper(II) diclofenac complexes: Synthesis, structural studies and interaction with albumins and calf-thymus DNA
  53. Heterocyclic thioamide/phosphine mixed-ligand silver(I) complexes: Synthesis, molecular structures, DNA-binding properties and antibacterial activity
  54. Manganese(II) complexes of the quinolone family member flumequine: Structure, antimicrobial activity and affinity for albumins and calf-thymus DNA
  55. A step-ladder manganese(iii) metallacrown hosting mefenamic acid and a manganese(ii)–mefanamato complex: synthesis, characterization and cytotoxic activity
  56. Ruthenium–arene complexes with NSAIDs: synthesis, characterization and bioactivity
  57. Extending the family of quinolone antibacterials to new copper derivatives: self-assembly, structural and topological features, catalytic and biological activity
  58. Manganese(ii) complexes with the non-steroidal anti-inflammatory drugs naproxen and mefenamic acid: synthesis, structure, antioxidant capacity, and interaction with albumins and DNA
  59. Nickel(II)-indomethacin mixed-ligand complexes: Synthesis, characterization, antioxidant activity and interaction with DNA and albumins
  60. Interaction of zinc(II) with the non-steroidal anti-inflammatory drug niflumic acid
  61. Toward Multifunctional Materials Incorporating Stepladder Manganese(III) Inverse-[9-MC-3]-Metallacrowns and Anti-Inflammatory Drugs
  62. Zinc complexes of diflunisal: Synthesis, characterization, structure, antioxidant activity, and in vitro and in silico study of the interaction with DNA and albumins
  63. Synthesis, structural, thermal characterization and interaction with calf-thymus DNA and albumins of cationic Ni(II) complexes with 2,2′-dipyridylamine and salicylaldehydes
  64. Nickel(ii)–naproxen mixed-ligand complexes: synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  65. Copper(I) halide complexes of 2,2,5,5-tetramethyl-imidazolidine-4-thione: Synthesis, structures, luminescence, thermal stability and interaction with DNA
  66. Copper(II) complexes with gatifloxacin
  67. Zinc complexes of flufenamic acid: Characterization and biological evaluation
  68. Ni(II) complexes with 2,2-dipyridylamine and salicylaldehydes: Synthesis, crystal structure and interaction with calf-thymus DNA and albumins
  69. Nickel(II) complexes of flufenamic acid: Characterization, structure and interaction with DNA and albumins
  70. Nickel(II) complexes of the non-steroidal anti-inflammatory drug tolfenamic acid: Synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  71. Cobalt(II) complexes of sparfloxacin
  72. Nickel-diflunisal complexes: synthesis, characterization, in vitro antioxidant activity and interaction with DNA and albumins
  73. Characterization and biological properties of copper(II)-ketoprofen complexes
  74. Dinuclear copper(I) complexes of N-methylbenzothiazole-2-thione: synthesis, structures, antibacterial activity and DNA interaction
  75. Co-NSAIDs
  76. Synthesis, characterization and biological evaluation of 99m Tc/Re–tricarbonyl quinolone complexes
  77. Pyridine and p-Nitrophenyl Oxime Esters with Possible Photochemotherapeutic Activity: Synthesis, DNA Photocleavage and DNA Binding Studies
  78. Alkyl and aryl sulfonyl p-pyridine ethanone oximes are efficient DNA photo-cleavage agents
  79. Cd - 5-Cl-saloH
  80. Cd - 5-Br-saloH
  81. Evaluation of O-alkyl and aryl sulfonyl aromatic and heteroaromatic amidoximes as novel potent DNA photo-cleavers
  82. Structure and biological activities of metal complexes of flumequine
  83. New copper(ii) complexes of the anti-inflammatory drug mefenamic acid: a concerted study including synthesis, physicochemical characterization and their biological evaluation
  84. On the Complexity of Dynamic Mechanism Design
  85. Copper(II) Inverse-[9-Metallacrown-3] Compounds Accommodating ­Nitrato or Diclofenac Ligands: Structure, Magnetism, and Biological Activity
  86. Cd - 5-nitro-saloH
  87. Mn-diclofenac complexes
  88. Copper-tolfenamato complexes
  89. Mn3-diclofenac
  90. Ni - mefanamato complexes
  91. Manganese(II)–sparfloxacinato complexes
  92. Cobalt-oxolinato complexes
  93. Cu - saloH
  94. Copper(II)–indomethacin complexes
  95. Thermal analysis and structural characterization of copper(II) complexes with salicyladehydes
  96. Cobalt(II) complexes of enrofloxacin
  97. Synthesis, thermal analysis, and spectroscopic and structural characterizations of tetranuclear nickel(II) cubane-type clusters with 2-hydroxybenzaldehydes or 2-hydroxyphenones
  98. Synthesis, characterization, thermal and DNA-binding properties of new zinc complexes with 2-hydroxyphenones
  99. Zinc-tolfenamato
  100. Manganese(II) complexes of tolfenamic acid
  101. Zinc complexes of mefenamic acid
  102. Zn saloH
  103. Nickel complexes of diclofenac
  104. New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
  105. Copper(II) complexes of flufenamic acid
  106. Manganese(II) complexes of niflumic acid
  107. Zinc complexes of oxolinic acid, flumequine, enrofloxacin
  108. Manganese(II) complexes of oxolinic acid and enrofloxacin
  109. Metal complexes of quinolones or NSAIDs: Perspective
  110. Zinc complexes of flumequine
  111. Copper complexes with ofloxacin and norfloxacin - synthesis, structure na bioactivity
  112. Copper(II) complexes of flumequine
  113. A [24-MC-6] Zinc Metallacoronate with a Nonsteroidal Antiinflammatory Drug as the Constructing Ligand
  114. First Palladium(II) and Platinum(II) Complexes from Employment of 2,6-Diacetylpyridine Dioxime: Synthesis, Structural and Spectroscopic Characterization, and Biological Evaluation
  115. Cobalt(II)-tolfenamato complexes
  116. Cobalt - naproxen
  117. Zinc complexes of tolfenamic acid
  118. Copper - diflunisal
  119. Nickel–quinolones-bipyam complexes
  120. Copper(II) complexes of naproxen / diclofenac
  121. Copper(ii) complexes of mefenamic acid
  122. Zinc complexes of sparfoxacin - levofloxacin
  123. Nickel complexes of enrofloxacin
  124. Nickel complexes of flumequine
  125. Metal - sparfloxacin complexes
  126. Zinc(II) complexes of enrofloxacin
  127. Nickel complexes of oxolinic acid
  128. Cobalt(ii) complexes of mefenamic acid
  129. Nickel complexes of sparfloxacin
  130. Structure and DNA-binding properties of bis(quinolonato)bis(pyridine)zinc(II) complexes
  131. Structure, cyclic voltammetry and DNA-binding properties of the bis(pyridine)bis(sparfloxacinato)nickel(II) complex
  132. Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)2]
  133. Zinc-oxolinato complexes
  134. Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties
  135. Magnesium complexes of ciprofloxacin
  136. Structure, antimicrobial activity and DNA-binding properties of the cobalt(II)–sparfloxacin complex
  137. Mononuclear metal complexes of the second-generation quinolone antibacterial agent enrofloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  138. Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: Structure–activity relationship
  139. Novel Copper(II) Complex ofN-Propyl-norfloxacin and 1,10-Phenanthroline with Enhanced Antileukemic and DNA Nuclease Activities
  140. Synthesis, characterization and DNA-binding of the mononuclear dioxouranium(VI) complex with ciprofloxacin
  141. Mononuclear dioxomolybdenum(VI) complexes with the quinolones enrofloxacin and sparfloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  142. Mononuclear copper(II) complexes with quinolones and nitrogen-donor heterocyclic ligands: Synthesis, characterization, biological activity and interaction with DNA
  143. Neutral mononuclear dioxomolybdenum(VI) and dioxouranium(VI) complexes of oxolinic acid: Characterization and biological evaluation
  144. Synthesis, characterization and interaction with DNA of mononuclear metal complexes with oxolinic acid
  145. Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: Synthesis, structure and bioactivity
  146. Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex
  147. Metal-pipemidato complexes
  148. Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2′-bipyridine
  149. Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid
  150. Copper-enrofloxacin complexes
  151. Cu(II) - sparfloxacin
  152. Metal-piroxicam complexes
  153. An Unprecedented Trinuclear Structure Involving Two High-Spin and One Spin-Crossover Iron(II) Centers
  154. Host-Guest Interaction of 12-MC-4, 15-MC-5, and Fused 12-MC-4 Metallacrowns with Mononuclear and Binuclear Carboxylato Complexes: Structure and Magnetic Behavior
  155. Preparation of Site-Differentiated Mixed Ligand and Mixed Ligand/Mixed Metal Metallacrowns
  156. Structurally Diverse Copper(II)−Carboxylato Complexes:  Neutral and Ionic Mononuclear Structures and a Novel Binuclear Structure
  157. Ni metallacrowns hosting a carboxylic herbicide
  158. CuII-herbicide complexes: structure and bioactivity
  159. Structurally diverse copper(II) herbicide complexes: mono- and bi-nuclear neutral or cationic complexes
  160. Mn(II) - MCPA